WeChat Mini Program
Old Version Features

A Randomized, Open-Label, Single-Dose, Two-Cycle Crossover Study to Evaluate the Bioequivalence and Safety of Lenvatinib and Lenvima® in Chinese Healthy Subjects

Zhongnan Xu,Yanli Wang,Guangwen Liu,Jiahui Chen,Wanhua Wang,Yang Cheng,Qing Ren,Yingzi Cui,Wei Yang,Zhengzhi Liu,Xuesong Chen,Jinling Xue,Tianying Chang,Xinyao Qu,Shuang Yu,Yannan Zhou,Kaibo Xu,Zhengjie Su,Qiaohuan Deng,Yicheng Zhao,Haimiao Yang

Expert Opinion on Investigational Drugs（2022）

Cited 1|Views23
Key words
Bioequivalence,biosimilars,lenvatinib,safety,thyroid cancer,VEGF
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined